PT  - JOURNAL ARTICLE
AU  - Vidt, Donald G.
TI  - The ALLHAT Trial
DP  - 2003 Mar 01
TA  - Cleveland Clinic Journal of Medicine
PG  - 263--269
VI  - 70
IP  - 3
4099  - http://www.ccjm.org/content/70/3/263.short
4100  - http://www.ccjm.org/content/70/3/263.full
SO  - Cleve Clin J Med2003 Mar 01; 70
AB  - The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT) compared four antihypertensive agents in patients 55 years and older: chlorthalidone, doxazosin, amlodipine, and lisinopril. The doxazosin arm was terminated early because of an excess of congestive heart failure. Chlorthalidone was at least equivalent to amlodipine and lisinopril in all of the outcomes measured, and was better in some, notably heart failure.